Medicago Inc. announces leading independent proxy firms recommend voting in favour of the arrangement with Mitsubishi Tanabe Pharma

03:13 EDT 19 Aug 2013 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
QUEBEC CITY, Aug. 19, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Pa...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Medicago Inc. announces leading independent proxy firms recommend voting in favour of the arrangement with Mitsubishi Tanabe Pharma"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Searches Linking to this Story